A pharmaceutical company is seeking emergency approval from the FDA to test an anti-inflammatory drug on COVID-19 patients.
A pharmaceutical company is seeking emergency approval from the FDA to test an anti-inflammatory drug on COVID-19 patients.
0 Comments